Clinical Trials Browser

Withdrawn × INDUSTRY × Imatinib Mesylate × Clear all

NCT06219733 2024-12-09

MP-VAC-206

Phase 2 Withdrawn

Dermoid Cyst

NCT00324077 2016-02-17

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase